Intellectual Property Patents

  • NEW YORK, Sept. 30- A federal jury in Texas on Friday night ordered Apple Inc to pay more than $302 million in damages for using VirnetX Holding Corp's patented internet security technology without permission in features including its FaceTime video conferencing application. The verdict came in a new trial in Tyler, Texas that had been ordered by the judge in the...

  • BRIEF-SPRINT PATENTS RULED AS VALID IN LITIGATION WITH COX. Sept 23-* Patents are not valid in litigation with cox communications inc- decision. Court of appeals for the federal circuit reverses delaware court that had ruled the patents were indefinite.

  • LAWSUIT RELATES TO COX COMPLAINT IN DELAWARE FEDERAL COURT THAT THE SPRINT PATENTS ARE INVALID AND NOT INFRINGED.

  • Price of innovation in pharma: Pro

    Kevin Sharer, Harvard Business School, discusses competition in the pharmaceutical industry and balancing drug prices and profits.

  • NEW YORK, Sept 14- Amid growing concerns by some U.S. lawmakers that federal officials may be granting patents that fuel abusive litigation, the head of the European Patent Office says his agency is producing better-quality patents than its American counterpart. Battistelli made his comments after USPTO Director Michelle Lee testified before the U.S. House...

  • How Xiaomi is navigating the smartphone war

    Hugo Barra, VP of Xiaomi Global, talks about how the company engages customers in India, and its development of a patent and IP war chest.

  • NEW YORK, Sept 1- Teva Pharmaceutical Industries on Thursday lost a third patent for its top-selling multiple sclerosis treatment as U.S. patent officials ruled that Copaxone did not deserve legal protection, bringing rivals one step closer toward selling generic versions. According to U.S. Food and Drug Administration data, Copaxone had been protected by...

  • NEW YORK, Sept 1- U.S. patent officials on Thursday invalidated a third patent for Teva Pharmaceutical Industries' $4 billion multiple sclerosis treatment Copaxone, saying it did not deserve legal protection, after cancelling two other patents on the drug last week. According to U.S. Food and Drug Administration data, Copaxone had been protected by five patents...

  • NEW YORK, Sept 1- U.S. patent officials on Thursday invalidated a third patent covering Teva Pharmaceutical Industries' $4 billion multiple sclerosis treatment Copaxone, after cancelling two other patents on the drug last week. The ruling came in a challenge at the U.S. According to the U.S. Food and Drug Administration, Copaxone is protected by five patents in...

  • PATENT AND TRADEMARK OFFICE PREVIOUSLY INVALIDATED TWO OTHER PATENTS ON 40 MG COPAXONE.

  • Should the government be blamed for EpiPen price hike?

    David Martin, M-CAM Founder, discusses the EpiPen pricing saga and his view that the patent office gave Mylan an unjustified monopoly on the drug.

  • Would Clinton hurt or help drug prices?

    Scott Gottlieb AEI resident fellow, and Sam Waksal, Kadmon Corporation, discuss whether regulations will impede innovation in the pharmaceutical industry.

  • WASHINGTON, Aug 24- Pharmaceutical company Mylan NV has won a round in its fight with Teva Pharmaceutical Industries Ltd at the U.S. Teva sells Copaxone based on patents licensed from Yeda Research& Development Co Ltd.. It said that IMS Health estimates sales of the drug to be $3.3 billion annually.

  • Teva drug patent invalidated by US regulator

    Shares of Teva Pharmaceutical Industries are plunging, as U.S. patent offices invalidated their drug patent. CNBC's Meg Tirrell reports.

  • WELLINGTON, Aug 18- ResMed Inc said on Thursday it has filed legal action to stop the alleged infringement of its patented technology by New Zealand- based medical device manufacturer Fisher& Paykel Healthcare. ResMed said in a statement it filed legal action with the U.S. International Trade Commission and the U.S. District Court for the Southern District of...

  • Aug 17- Johnson& Johnson said a U.S. court had held its patent for autoimmune drug Remicade invalid, ruling in favor of two companies seeking to bring a cheaper version of the blockbuster drug to market. Remicade, J&J's biggest product, had $6.6 billion in sales last year. "Assuming biosimilar competition, we think Remicade revenues will decline by just over $1...

  • NEW YORK, Aug 4- Apple Inc deserved the hundreds of millions of dollars in damages Samsung Electronics Co Ltd paid for infringing patented designs of the iPhone because the product's distinctive look drives people to purchase it, a group of design industry professionals told the U.S. Supreme Court on Thursday. They include famous fashion names Calvin Klein,...

  • NEW YORK/ ZURICH, Aug 2- Swiss digital TV security company Kudelski on Tuesday reached a settlement with Apple Inc, ending a patent dispute in the United States and Europe and removing a threat to Apple's video streaming features in devices sold in Germany. Kudelski's stock traded up 1.5 percent on the Swiss Stock Exchange. Apple was down 1.5 percent in New York...

  • Aug 1- A federal judge has thrown out a verdict requiring Apple Inc to pay VirnetX Holding Corp $625.6 million for infringing four patents relating to Internet security technology, causing VirnetX's share price to plunge. VirnetX shares were down $1.93, or 44.6 percent, at $2.40 in Monday morning trading, after earlier falling to $2.14. District Judge Robert...

  • SAN FRANCISCO, July 29- Apple Inc on Friday asked the U.S. Supreme Court to clear the way for the iPhone maker to secure hundreds of millions in damages from Samsung Electronics Co Ltd in a case over smartphone design patents. Apple said there was no need for the Supreme Court to send the case back to a lower court for further proceedings. Its efforts were partially...